請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30249
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 閔明源(Ming-Yuan Min) | |
dc.contributor.author | Pei-Yu Shih | en |
dc.contributor.author | 施佩妤 | zh_TW |
dc.date.accessioned | 2021-06-13T01:46:27Z | - |
dc.date.available | 2008-07-19 | |
dc.date.copyright | 2007-07-19 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-10 | |
dc.identifier.citation | 1. Pertovaara A. 2006. Noradrenergic pain modulation. Progress in Neurobiology 80: 53-83
2. Olson L, Fuxe K. 1972. Further Mapping out of Central Noradrenaline Neuron Systems - Projections of Subcoeruleus Area. Brain Research 43: 289-95 3. Squire LR, Bloom FE, McConnell SK, Roberts JL, Spitzer NC, Zigmond MJ. 2003. Fundamental Neuroscience: Academic Press 4. Paxinos G. 1995. The Rat Nervous System: Academic Press 5. Levitt P, Moore RY. 1979. Origin and Organization of Brain-Stem Catecholamine Innervation in the Rat. Journal of Comparative Neurology 186: 505-28 6. Min MY, Hsu PC, Lu HW, Lin CJ, Yang HW. 2007. Postnatal development of noradrenergic terminals in the rat trigeminal motor nucleus: A light and electron microscopic immunocytochemical analysis. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology 290: 96-107 7. Paxinos G, Watson C. 1998. The Rat Brain: Academic Press 8. Holden JE, Pizzi JA. 2003. The challenge of chronic pain. Advanced Drug Delivery Reviews 55: 935-48 9. Dickenson AH, Bee LA, Suzuki R. 2005. Pains, gains, and midbrains. Proceedings of the National Academy of Sciences of the United States of America 102: 17885-6 10. Woolf CJ, Salter MW. 2000. Neuroscience - Neuronal plasticity: Increasing the gain in pain. Science 288: 1765-8 11. Ikeda H, Heinke B, Ruscheweyh R, Sandkuhler J. 2003. Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 299: 1237-40 12. Coull JAM, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De Koninck P, and De Koninck Y. 2003. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424: 938-42 13. Mantyh PW, Hunt SP. 2004. Setting the tone: superficial dorsal horn projection neurons regulate pain sensitivity. Trends in Neurosciences 27: 582-4 14. Porreca F, Ossipov MH, Gebhart GF. 2002. Chronic pain and medullary descending facilitation. Trends in Neurosciences 25: 319-25 15. Suzuki R, Morcuende S, Webber M, Hunt SP, Dickenson AH. 2002. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nature Neuroscience 5: 1319-26 16. Fields H. 2004. State-dependent opioid control of pain. Nature Reviews Neuroscience 5: 565-75 17. Price DD. 2000. Neuroscience - Psychological and neural mechanisms of the affective dimension of pain. Science 288: 1769-72 18. Hunt SP, Mantyh PW. 2001. The molecular dynamics of pain control. Nature Reviews Neuroscience 2: 83-91 19. Millan MJ. 1999. The induction of pain: An integrative review. Progress in Neurobiology 57: 1-164 20. Sandkuhler J. 2000. Learning and memory in pain pathways. Pain 88: 113-8 21. Reynolds DV. 1969. Surgery in Rat during Electrical Analgesia Induced by Focal Brain Stimulation. Science 164: 444-5 22. Mayer DJ. 1984. Analgesia Produced by Electrical-Stimulation of the Brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry 8: 557-64 23. Fields HL, Basbaum AI. 1978. Brain-Stem Control of Spinal Pain-Transmission Neurons. Annual Review of Physiology 40: 217-48 24. Aimone LD, Bauer CA, Gebhart GF. 1988. Brain-Stem Relays Mediating Stimulation-Produced Antinociception from the Lateral Hypothalamus in the Rat. Journal of Neuroscience 8: 2652-63 25. Behbehani MM, Park MR, Clement ME. 1988. Interactions between the Lateral Hypothalamus and the Periaqueductal Gray. Journal of Neuroscience 8: 2780-7 26. Holden JE, Naleway E. 2001. Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by alpha(1)- and alpha(2)-adrenoceptors. Brain Research 911: 27-36 27. Holden JE, Van Poppel AY, Thomas S. 2002. Antinociception from lateral hypothalamic stimulation may be mediated by NK1 receptors in the A7 catecholamine cell group in rat. Brain Research 953: 195-204 28. Mayer DJ, Wolfle TL, Akil H, Carder B, Liebeski JC. 1971. Analgesia from Electrical Stimulation in Brainstem of Rat. Science 174: 1351-4 29. Hosobuchi Y, Adams JE, Linchitz R. 1977. Pain Relief by Electrical-Stimulation of Central Gray-Matter in Humans and Its Reversal by Naloxone. Science 197: 183-6 30. Liebeski.Jc, Guilbaud G, Besson JM, Oliveras JL. 1973. Analgesia from Electrical-Stimulation of Periaqueductal Gray Matter in Cat - Behavioral Observations and Inhibitory Effects on Spinal-Cord Interneurons. Brain Research 50: 441-6 31. Peng YB, Lin Q, Willis WD. 1996. Involvement of alpha-2 adrenoceptors in the periaqueductal gray-induced inhibition of dorsal horn cell activity in rats. Journal of Pharmacology and Experimental Therapeutics 278: 125-35 32. Bajic D, Van Bockstaele EJ, Proudfit HK. 2001. Ultrastructural analysis of ventrolateral periaqueductal gray projections to the A7 catecholamine cell group. Neuroscience 104: 181-97 33. Proudfit HK, Monsen M. 1999. Ultrastructural evidence that substance P neurons form synapses with noradrenergic neurons in the A7 catecholamine cell group that modulate nociception. Neuroscience 91: 1499-513 34. Bajic D, Proudfit HK. 1999. Projections of neurons in the periaqueductal gray to pontine and medullary catecholamine cell groups involved in the modulation of nociception. Journal of Comparative Neurology 405: 359-79 35. Yaksh TL, Wilson PR. 1979. Spinal Serotonin Terminal System Mediates Antinociception. Journal of Pharmacology and Experimental Therapeutics 208: 446-53 36. Zhuo M, Gebhart GF. 1991. Spinal Serotonin Receptors Mediate Descending Facilitation of a Nociceptive Reflex from the Nuclei Reticularis-Gigantocellularis and Gigantocellularis Pars-Alpha in the Rat. Brain Research 550: 35-48 37. Sagen J, Proudfit HK. 1981. Hypoalgesia Induced by Blockade of Noradrenergic Projections to the Raphe Magnus - Reversal by Blockade of Noradrenergic Projections to the Spinal-Cord. Brain Research 223: 391-6 38. Clark FM, Proudfit HK. 1991. Projections of Neurons in the Ventromedial Medulla to Pontine Catecholamine Cell Groups Involved in the Modulation of Nociception. Brain Research 540: 105-15 39. Helke CJ, Shults CW, Chase TN, Odonohue TL. 1984. Autoradiographic Localization of Substance-P Receptors in Rat Medulla - Effect of Vagotomy and Nodose Ganglionectomy. Neuroscience 12: 215-23 40. Ljungdahl A, Hokfelt T, Nilsson G, Goldstein M. 1978. Distribution of Substance P-Like Immunoreactivity in Central Nervous-System of Rat.2. Light Microscopic Localization in Relation to Catecholamine-Containing Neurons. Neuroscience 3: 945-76 41. Yeomans DC, Proudfit HK. 1990. Projections of Substance-P-Immunoreactive Neurons Located in the Ventromedial Medulla to the a7 Noradrenergic Nucleus of the Rat Demonstrated Using Retrograde Tracing Combined with Immunocytochemistry. Brain Research 532: 329-32 42. Holden JE, Proudfit HK. 1998. Enkephalin neurons that project to the A7 catecholamine cell group are located in nuclei that modulate nociception: Ventromedial medulla. Neuroscience 83: 929-47 43. Yaksh TL. 1985. Pharmacology of Spinal Adrenergic Systems Which Modulate Spinal Nociceptive Processing. Pharmacology Biochemistry and Behavior 22: 845-58 44. Janss AJ, Jones SL, Gebhart GF. 1987. Effect of Spinal Norepinephrine Depletion on Descending Inhibition of the Tail Flick Reflex from the Locus-Coeruleus and Lateral Reticular Nucleus in the Rat. Brain Research 400: 40-52 45. Proudfit HK. 1988. Pharmacologic Evidence for the Modulation of Nociception by Noradrenergic Neurons. Progress in Brain Research 77: 357-70 46. Aran S, Proudfit HK. 1990. Antinociceptive Interactions between Intrathecally Administered Alpha-Noradrenergic Agonists and 5'-N-Ethylcarboxamide Adenosine. Brain Research 519: 287-93 47. Gordh T. 1988. Epidural Clonidine for Treatment of Postoperative Pain after Thoracotomy - a Double-Blind Placebo-Controlled Study. Acta Anaesthesiologica Scandinavica 32: 702-9 48. Clark FM, Proudfit HK. 1991. The Projection of Noradrenergic Neurons in the a7 Catecholamine Cell Group to the Spinal-Cord in the Rat Demonstrated by Anterograde Tracing Combined with Immunocytochemistry. Brain Research 547: 279-88 49. Yeomans DC, Proudfit HK. 1992. Antinociception Induced by Microinjection of Substance-P into the a7-Catecholamine Cell Group in the Rat. Neuroscience 49: 681-91 50. Yeomans DC, Clark FM, Paice JA, Proudfit HK. 1992. Antinociception Induced by Electrical-Stimulation of Spinally Projecting Noradrenergic Neurons in the a7 Catecholamine Cell Group of the Rat. Pain 48: 449-61 51. von Euler US, Gaddum JH. 1931. An unidentified depressor substance in certain tissue extracts. Journal of Physiology-London 72: 74-87 52. Raffa RB. 1998. Possible role(s) of neurokinins in CNS development and neurodegenerative or other disorders. Neuroscience and Biobehavioral Reviews 22: 789-813 53. Khawaja AM, Rogers DF. 1996. Tachykinins: Receptor to effector. International Journal of Biochemistry & Cell Biology 28: 721-38 54. Satake H, Kawada T. 2006. Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors. Current Drug Targets 7: 963-74 55. Chen LW, Yung KKL, Chan YS. 2004. Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease. Current Drug Targets 5: 197-206 56. Ebner K, Rupniak NM, Saria A, Singewald N. 2004. Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proceedings of the National Academy of Sciences of the United States of America 101: 4280-5 57. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NM. 1998. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640-5 58. Quirion R, Dam TV. 1986. Ontogeny of Substance-P Receptor-Binding Sites in Rat-Brain. Journal of Neuroscience 6: 2187-99 59. Jonsson G, Hallman H. 1982. Substance-P Counteracts Neurotoxin Damage on Norepinephrine Neurons in Rat-Brain during Ontogeny. Science 215: 75-7 60. Nakai K, Kasamatsu T. 1984. Accelerated Regeneration of Central Catecholamine Fibers in Cat Occipital Cortex - Effects of Substance-P. Brain Research 323: 374-9 61. Lembeck F, Holzer P. 1979. Substance-P as Neurogenic Mediator of Antidromic Vasodilation and Neurogenic Plasma Extravasation. Naunyn-Schmiedebergs Archives of Pharmacology 310: 175-83 62. Trafton JA, Abbadie C, Basbaum AI. 2001. Differential contribution of substance P and neurokinin a to spinal cord neurokinin-1 receptor signaling in the rat. Journal of Neuroscience 21: 3656-64 63. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJH, Basbaum AI. 1998. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 392: 390-4 64. De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith A JH, Laird JMA, Belmonte C, Cervero F, and Hunt SP. 1998. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392: 394-7 65. Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K. 2007. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128: 209-14 66. Gilbert R, Ryan JS, Horackova M, Smith FM, Kelly MEM. 1998. Actions of substance P on membrane potential and ionic currents in guinea pig stellate ganglion neurons. American Journal of Physiology-Cell Physiology 43: C892-C903 67. Velimirovic BM, Koyano K, Nakajima S, Nakajima Y. 1995. Opposing Mechanisms of Regulation of a G-Protein-Coupled Inward Rectifier K+ Channel in Rat-Brain Neurons. Proceedings of the National Academy of Sciences of the United States of America 92: 1590-4 68. Inoue K, Nakazawa K, Inoue K, Fujimori K. 1995. Nonselective Cation Channels Coupled with Tachykinin Receptors in Rat Sensory Neurons. Journal of Neurophysiology 73: 736-42 69. Weinreich D, Moore KA, Taylor GE. 1997. Allergic inflammation in isolated vagal sensory ganglia unmasks silent NK-2 tachykinin receptors. Journal of Neuroscience 17: 7683-93 70. Clapham DE. 2003. TRP channels as cellular sensors. Nature 426: 517-24 71. Delmas P, Wanaverbecq N, Abogadie FC, Mistry M, Brown DA. 2002. Signaling microdomains define the specificity of receptor-mediated InsP(3) pathways in neurons. Neuron 34: 209-20 72. Li HS, Xu XZS, Montell C. 1999. Activation of a TRPC3-dependent cation current through the neurotrophin BDNF. Neuron 24: 261-73 73. Li Y, Jia YC, Cui K, Li N, Zheng ZY, Wang YZ, and Yuan XB 2005. Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor. Nature 434: 894-8 74. Oh EJ, Gover TD, Cordoba-Rodriguez R, Weinreich D. 2003. Substance P evokes cation currents through TRP channels in HEK293 cells. Journal of Neurophysiology 90: 2069-73 75. Chen LW, Wei LC, Liu HL, Rao ZR. 2000. Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat. Brain Research 873: 155-9 76. Shen KZ, North RA. 1992. Substance-P Opens Cation Channels and Closes Potassium Channels in Rat Locus-Ceruleus Neurons. Neuroscience 50: 345-53 77. Neher E. 1992. Correction for Liquid Junction Potentials in Patch Clamp Experiments. Methods in Enzymology 207: 123-31 78. Jenkinson KM, Mann PT, Southwell BR, Furness JB. 2000. Independent endocytosis of the NK1 and NK3 tachykinin receptors in neurons of the rat myenteric plexus. Neuroscience 100: 191-9 79. Tousignant C, Guillemette G, Drapeau G, Telemaque S, Dion S, Regoli D. 1990. I-125 Bh[Sar9,Met(O2)11]-Sp, a New Selective Ligand for the Nk-1 Receptor in the Central-Nervous-System. Brain Research 524: 263-70 80. Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel JF, Blanchard JC, and Laduron PM 1991. Pharmacological Properties of a Potent and Selective Nonpeptide Substance-P Antagonist. Proceedings of the National Academy of Sciences of the United States of America 88: 10208-12 81. Chung WC, Kermode JC. 2005. Suramin disrupts receptor-G protein coupling by blocking association of G protein alpha and beta gamma subunits. Journal of Pharmacology and Experimental Therapeutics 313: 191-8 82. Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, and Bunting S. 1990. Selective-Inhibition of Receptor-Coupled Phospholipase-C-Dependent Processes in Human Platelets and Polymorphonuclear Neutrophils. Journal of Pharmacology and Experimental Therapeutics 255: 756-68 83. Venkatachalam K, Zheng F, Gill DL. 2003. Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. Journal of Biological Chemistry 278: 29031-40 84. Sakakibara M, Inoue H, Yoshioka T. 1998. Evidence for the involvement of inositol trisphosphate but not cyclic nucleotides in visual transduction in Hermissenda eye. Journal of Biological Chemistry 273: 20795-801 85. Dellis O, Dedos SG, Tovey SC, Taufiq-Ur-Rahman, Dubel SJ, Taylor CW. 2006. Ca2+ entry through plasma membrane IP3 receptors. Science 313: 229-33 86. Kubota M, Kasahara T, Nakamura T, Ishiwata M, Miyauchi T, Kato T. 2006. Abnormal Ca2+ dynamics in transgenic mice with neuron-specific mitochondrial DNA defects. Journal of Neuroscience 26: 12314-24 87. Plant TD, Schaefer M. 2003. TRPC4 and TRPC5: receptor-operated Ca2+-permeable nonselective cation channels. Cell Calcium 33: 441-50 88. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, and Kaneko M. 1987. K-252 Compounds, Novel and Potent Inhibitors of Protein-Kinase-C and Cyclic Nucleotide-Dependent Protein-Kinases. Biochemical and Biophysical Research Communications 142: 436-40 89. Hidaka H, Kobayashi R. 1992. Pharmacology of Protein-Kinase Inhibitors. Annual Review of Pharmacology and Toxicology 32: 377-97 90. Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K. 1997. 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P-3-induced Ca2+ release. Journal of Biochemistry 122: 498-505 91. Lievremont JP, Bird GS, Putney JW. 2005. Mechanism of inhibition of TRPC cation channels by 2-aminoethoxydiphenylborane. Molecular Pharmacology 68: 758-62 92. Sargeant P, Clarkson WD, Sage SO, Heemskerk JWM. 1992. Calcium Influx Evoked by Ca-2+ Store Depletion in Human Platelets Is More Susceptible to Cytochrome-P-450 Inhibitors Than Receptor-Mediated Calcium Entry. Cell Calcium 13: 553-64 93. Gee CE, Benquet P, Gerber U. 2003. Group I metabotropic glutamate receptors activate a calcium-sensitive transient receptor potential-like conductance in rat hippocampus. Journal of Physiology-London 546: 655-64 94. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxachamiec A, Leigh BK, Mccarthy SA, Moores KE, and Rink TJ. 1990. Sk-and-F-96365, a Novel Inhibitor of Receptor-Mediated Calcium Entry. Biochemical Journal 271: 515-22 95. Kim SJ, Kim YS, Yuan JP, Petralia RS, Worley PF, Linden DJ. 2003. Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1. Nature 426: 285-91 96. Siegel BW, Wiech NL. 1976. Rmi 12330a - Inhibitor of Cholera Toxin Induced Intestinal Hypersecretion Which Also Inhibits Adenylate-Cyclase Activity. Gastroenterology 70: 937 97. Jung S, Muhle A, Schaefer M, Strotmann R, Schultz G, Plant TD. 2003. Lanthanides potentiate TRPC5 currents by an action at extracellular sites close to the pore mouth. Journal of Biological Chemistry 278: 3562-71 98. Nuseir K, Proudfit HK. 2000. Bidirectional modulation of nociception by GABA neurons in the dorsolateral pontine tegmentum that tonically inhibit spinally projecting noradrenergic A7 neurons. Neuroscience 96: 773-83 99. Williams JT, Marshall KC. 1987. Membrane-Properties and Adrenergic Responses in Locus-Coeruleus Neurons of Young-Rats. Journal of Neuroscience 7: 3687-94 100. Holden JE, Schwartz EJ, Proudfit HK. 1999. Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha(1)- and alpha(2)-adrenoceptors. Neuroscience 91: 979-90 101. Hanley MR, Lee CM, Jones LM, Michell RH. 1980. Similar Effects of Substance-P and Related Peptides on Salivation and on Phosphatidylinositol Turnover in Rat Salivary-Glands. Molecular Pharmacology 18: 78-83 102. Hunter JC, Goedert M, Pinnock RD. 1985. Mammalian Tachykinin-Induced Hydrolysis of Inositol Phospholipids in Rat-Brain Slices. Biochemical and Biophysical Research Communications 127: 616-22 103. Maggi CA. 1995. The Mammalian Tachykinin Receptors. General Pharmacology 26: 911-44 104. Sculptoreanu A, de Groat WC. 2003. Protein kinase C is involved in neurokinin receptor modulation of N- and L-type Ca2+ channels in DRG neurons of the adult rat. Journal of Neurophysiology 90: 21-31 105. Nakajima Y, Tsuchida K, Negishi M, Ito S, Nakanishi S. 1992. Direct Linkage of 3 Tachykinin Receptors to Stimulation of Both Phosphatidylinositol Hydrolysis and Cyclic-Amp Cascades in Transfected Chinese-Hamster Ovary Cells. Journal of Biological Chemistry 267: 2437-42 106. Zhou Q, Kindlundh AMS, Hallberg M, Nyberg F. 2004. The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal. Peptides 25: 1951-7 107. Minke B, Cook B. 2002. TRP channel proteins and signal transduction. Physiological Reviews 82: 429-72 108. Ramsey IS, Delling M, Clapham DE. 2006. An introduction to TRP channels. Annual Review of Physiology 68: 619-47 109. Montell C. 2005. The TRP superfamily of cation channels. Sci STKE 2005: re3 110. Montell C, Birnbaumer L, Flockerzi V, Bindels RJ, Bruford EA, Caterina MJ, Clapham DE, Harteneck C, Heller S, Julius D, Kojima I, Mori Y, Penner R, Prawitt D, Scharenberg AM, Schultz G, Shimizu N, Zhu MX. 2002. A unified nomenclature for the superfamily of TRP cation channels. Molecular Cell 9: 229-31 111. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. 1999. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397: 259-63 112. Smyth JT, Lemonnier L, Vazquez G, Bird GS, Putney JW. 2006. Dissociation of regulated trafficking of TRPC3 channels to the plasma membrane from their activation by phospholipase C. Journal of Biological Chemistry 281: 11712-20 113. Bezzerides VJ, Ramsey IS, Kotecha S, Greka A, Clapham DE. 2004. Rapid vesicular translocation and insertion of TRP channels. Nature Cell Biology 6: 709-20 114. Estacion M, Li S, Sinkins WG, Gosling M, Bahra P, Poll C, Westwick J, and Schilling WP. 2004. Activation of human TRPC6 channels by receptor stimulation. Journal of Biological Chemistry 279: 22047-56 115. Inoue R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S, Ito Y, and Mori Y. 2001. The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca2+-permeable cation channel. Circulation Research 88: 325-32 116. Hardie RC. 2003. Regulation of TRP channels via lipid second messengers. Annual Review of Physiology 65: 735-59 117. Patterson RL, van Rossum DB, Nikolaidis N, Gill DL, and Snyder SH. 2002. Phospholipase C-gamma is required for agonist-induced Ca2+ entry. Cell 111: 529-41 118. van Rossum DB, Patterson RL, Sharma S, Barrow RK, Kornberg M, Gill DL, and Snyder SH. 2005. Phospholipase C gamma 1 controls surface expression of TRPC3 through an intermolecular PH domain. Nature 434: 99-104 119. Patterson RL, van Rossum DB, Nikolaidis N, Gill DL, Snyder SH. 2005. Phospholipase C-gamma: diverse roles in receptor-mediated calcium signaling. Trends in Biochemical Sciences 30: 688-97 120. Venkatachalam K, Zheng F, Gill DL. 2003. Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. Journal of Biological Chemistry 278: 29031-40 121. Liu MY, Parker LL, Wadzinski BE, Shieh BH. 2000. Reversible phosphorylation of the signal transduction complex in Drosophila photoreceptors. Journal of Biological Chemistry 275: 12194-9 122. Zhu MH, Chae M, Kim HJ, Lee YM, Kim MJ, Jin NG, Yang DK, So I, and Kim KW. 2005. Desensitization of canonical transient receptor potential channel 5 by protein kinase C. American Journal of Physiology-Cell Physiology 289: C591-C600 123. Kwan HY, Huang Y, Yao XQ. 2006. Protein kinase C can inhibit TRPC3 channels indirectly via stimulating protein kinase G. Journal of Cellular Physiology 207: 315-21 124. Trebak M, Hempel N, Wedel BJ, Smyth JT, Bird GS, Putney JW. 2005. Negative regulation of TRPC3 channels by protein kinase C-mediated phosphorylation of serine 712. Molecular Pharmacology 67: 558-63 125. Nichols ML, Allen BJ, Rogers SD, Ghilardi JR, Honore P, Luger NM, Finke MP, Li J, Lappi DA, Simone DA, and Mantyh PW. 1999. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 286: 1558-61 126. Ikeda H, Stark J, Fischer H, Wagner M, Drdla R, Jager T, and Sandkuhler J. 2006. Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 312: 1659-62 127. Liu XH, Andre D, Puizillout JJ. 1998. Substance P post-synaptically potentiates glutamate-induced currents in dorsal vagal neurons. Brain Research 804: 95-104 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30249 | - |
dc.description.abstract | 下傳止痛神經迴路(descending antinociceptive neuronal circuitry)中的數個核區,包括PAG、VMM及LH,皆為腦部控制脊髓背角痛覺傳遞的重要構造。各項研究結果證實此三核區均會投射到腦幹A7兒茶酚胺細胞群 (catecholamine cell group),且投射細胞多為可分泌物質P (substance P) 的神經元,暗示物質P在A7核區極有可能扮演了相當重要的角色,進而影響下傳止痛神經迴路。我們的研究結果顯示在A7核區中,依照分泌正腎上腺素 (norepinephrine) 與否可以概分為兩群細胞,分別是”正腎上腺素神經元” (noradrenergic) 與”非正腎上腺素神經元”(non-noradrenergic)。染色結果顯示在A7核區中,不論在正腎上腺素神經元之間或是正腎上腺素神經元與非正腎上腺素神經元之間均具有連結的存在,暗示A7核區中神經元之間具有複雜的調控機制。在具有A7核區的腦薄片 (brain slice) 給予物質P後,可以觀察到正腎上腺素神經元及部分的非正腎上腺素神經元均產生自發性動作電位頻率加快及膜電位去極化的現象。在voltage-clamp下,物質P所造成的膜電位去極化可以表示為箝制電流 (holding current) 的增大。藉由RP67580, suramin, U73122之藥理測試,證實物質P所造成的箝制電流變化是透過”物質P-NK1受體 (neurokinin-1 receptor)-G蛋白-磷脂酶C (phospholipase C)”此一路徑所造成的。相對的,三磷酸肌 (inositol triphosphate) 、雙酸甘油酯 (diacyl glycerol)及蛋白質激酶A (protein kinase A) 路徑的相關藥物則無法抑制物質P造成的箝制電流變化。值得注意的是,雙酸甘油酯興奮劑 (OAG) 反而能增進物質P造成的箝制電流,顯示雙酸甘油酯對於物質P的作用具有促進的功能。另外蛋白質激酶C (protein kinase C) 則可以調控物質P箝制電流的去敏感化 (desensitization),而此一去敏感化效應需要有細胞外鈣離子的參與。物質P最終會透過開啟一無選擇性陽離子通道 (nonselective cation channe) 而造成箝制電流的變化。此一通道的反轉電位接近於-2 mV;且在三種常用的transient receptor potential (TRP) 通道抑制劑下,物質P的反應皆會被顯著抑制。綜合以上結果,此篇研究證實了物質P在A7正腎上腺素神經元的作用主要是透過磷脂酶C開啟一”類TRP通道” (TRP-like channel)而導致細胞興奮性的提高,可能進而調控下傳止痛神經迴路而影響痛覺在脊髓背角的傳遞。 | zh_TW |
dc.description.abstract | Previous morphological studies showed that neurons in A7 catecholamine cell group receive nerve terminals releasing substance-P (SP) from several descending pain modulation nuclei (PAG, VMM and LH), A7 neurons are therefore believed to play important roles in regulating nociception. In this study, we provided physiological evidence for this argument. Firstly, two kinds of neurons in A7 nucleus were identified based on norepinephrine production. Physical contacts observed between these noradrenergic (NAergic) neurons and non-noradrenergic (non-NAergic) neurons displayed the complex regulation among neurons in A7 nucleus. Application of SP consistently increased the firing frequency of NAergic neurons and some of the non-NAergic neurons. The mechanism under SP function in A7 NAergic neurons was then explored. Holding current of these NAergic neurons were significantly elevated upon bath application of 0.2 μM SP. This response can be blocked by RP 67580 (NK1 receptor antagonist), by internally applied 10 μM suramine (uncoupling G protein from the receptor), and by U73122 (phospholipase C blocker), therefore showed that the effect of SP was mediated through NK1 receptor, G protein, and phospholipase C-dependent mechanism. BAPTA, heparin and inositol 1,4,5-triphosphate via the patch pipette had no effect on SP-induced current. Addition of DAG analogue (OAG) and DAG lipase inhibitor (RHC80267) had no effect on SP-induced response either. Notably, SP-induced current in the presence of OAG were larger than SP alone suggested that generation of DAG alone may not fully account for activation of SP-induced current. In addition, PKC inhibitor significantly attenuated the desensitization of SP-induced current; calcium influx was also an essential component of this PKC regulated desensitization. Three evidences showed that SP-induced current was caused by open a transient receptor potential (TRP)-like channel. The conductance was increased during SP application, the reversal potential of this current was around -2mV, and adding three TRP channel blockers could consistently depress this inward current. Taken together, the electrophysiological and pharmacological properties of the SP-induced inward current are consistent with the involvement of TRP-like channels whereas the identification and function of this TRP-like channel still needs further investigation. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T01:46:27Z (GMT). No. of bitstreams: 1 ntu-96-R94b41013-1.pdf: 1869526 bytes, checksum: bd23d4aa564fe1304394a35d30f6939e (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | Introduction……………………………………………………………………….-1-
A7: the noradrenergic nucleus in the rostral brainstem………...……………..-1- The role of A7 in pain modulation………...…………………..………………..-2- What is Pain?……………………………………………………………...…-2- How is Pain Regulated?..................................................................................-3- The Ascending Pathway……………………...…………………...…………-4- The Descending Pathway…………………………………………..………..-5- Higher Order Neurons- Lateral Hypothalamus (LH)……………………..-6- Periaqueductal Grey (PAG)……………………………………………….-6- Ventromedial Medulla (VMM)…………………………………………….-8- A7 Noradrenergic Cell Group…………………………………………….-9- Substance P Role in Descending Pain Transmission………….……………...-10- Substance P: First Tachykinin………………………………………………-11- Major Biological Actions of SP in CNS……………………………………-11- The Pain-Modulation Role of Substance P in Brainstem…………………..-12- Two Major Mechanisms Under Substance P Activation………………….-13- Objective………………………………………………………………………..-14- Materials and Methods…………………………………………………………-16- Results……………………………………………………………………………...-22- Two Major Neuron Types in A7 Region: Noradrenergic and Non-noradrenergic Neurons………………………………………………………………………-22- Location and Interaction of Noradrenergic Neurons in A7 Region...............-22- Non-noradrenergic Neurons in A7 Region....................................................-24- Contacts between Noradrenergic and Non-noradrenergic neurons………...-24- VIII Substance P Action on Neurons in A7 Region……………………………….-25- Excitatory Responses Induced by Substance P…………………………….-25- NK1R, G Protein and Phospholipase C Dependence………………………-26- DAG Potentiates the Substance P Response………………………………..-28- IP3 and PKA Pathway Independence……………………………………….-29- PKC Mediates Desensitization of Substance P-Induced Response………...-30- TRP-like Channels Mediate the Inward Current Induced by Substance P…-31- Slow Substance P Postsynaptic Currents Induced by Electrical Stimulus…-33- Discussion………………………………………………………………………..-35- Cellular Interactions Between Neurons in A7………………………………….-35- Cellular Mechanisms Underlying SP Activation……………………………….-38- Target Channel of SP Activation………………………………………………..-39- PKC Determines the Desensitization Response………………………………..-42- Functional Role of SP in A7 NAergic neurons…………………………………-43- Reference………………………………………………………………………...-45- Figures…………………………………………………………………………...-57- | |
dc.language.iso | en | |
dc.title | 物質P透過類TRP通道對大鼠A7核區兒茶酚胺神經細胞群興奮性調控之機制研究 | zh_TW |
dc.title | Substance P Activates a TRP-like Channel to Increase Excitability of Neurons in A7 Catecholamine Cell Group in Rats | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 楊琇雯(Hsiu-Wen Yang),連正章(Cheng-Chang Lien),陳志成(Chih-Cheng Chen) | |
dc.subject.keyword | 物質P,類TRP通道,腦幹,A7腦區,正腎上腺素神經元,痛覺傳遞,痛覺, | zh_TW |
dc.subject.keyword | substance P,TRP-like channel,brainstem,A7 region,noradrenergic neurons,pain transmission,nociception, | en |
dc.relation.page | 75 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-07-11 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 動物學研究研究所 | zh_TW |
顯示於系所單位: | 動物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 1.83 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。